Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 592Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 508Specimen Handling 504Nivolumab 408Cisplatin 370Carboplatin 359Biopsy 304Blood Specimen Collection 295Radiosurgery 284Paclitaxel 274Surveys and Questionnaires 268Gemcitabine 267Standard of Care 266fludarabine 261Dexamethasone 258Drug Therapy 257venetoclax 247Bevacizumab 246Oxaliplatin 206Rituximab 196Capecitabine 196Radiation 189Fluorouracil 186Ipilimumab 185durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 172

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Particle Accelerators × 1 year × Clear all
NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

Dartmouth-Hitchcock Medical Center

Phase NA Not yet recruiting
10 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡